Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated 3 minutes ago
Opinion/decision on a Paediatric investigation plan (PIP): Idefirix, imlifidase, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Renal and urinary disorders, PIP number:
11 minutes ago
Opinion/decision on a Paediatric investigation plan (PIP): Idefirix, imlifidase, decision type: P...
Human medicines European public assessment report (EPAR): NeoRecormon, epoetin beta, Date of authorisation: 16/07/1997, Revision: 35, Status: Authorised
13 minutes ago
Human medicines European public assessment report (EPAR): NeoRecormon, epoetin beta, Date of...
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised
28 minutes ago
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation...
Medicine shortage communication (MSC): TEGSEDI® (inotersen sodium, 284 mg solution for injection in prefilled syringe): planned marketing cessation (discontinuation)
about 1 hour ago
Medicine shortage communication (MSC): TEGSEDI® (inotersen sodium, 284 mg solution for injection...
Opinion/decision on a Paediatric investigation plan (PIP): Rezzayo, rezafungin acetate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0343/2024
about 1 hour ago
Opinion/decision on a Paediatric investigation plan (PIP): Rezzayo, rezafungin acetate, decision type...
Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, PIP number: P/0028/2023
about 2 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM...